PierPass LLC – Trademark Portfolio

Entity Type: 16

PierPass LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include OFFPEAK and PIERPASS. The owner is based in Westminster, CA.

5555 Garden Grove Blvd., Suite 365

Westminster, CA 92683

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PIERPASS
PIERPASS
Registered 2005
OFFPEAK
OFFPEAK
Registered 2005
PIERPASS
PIERPASS
Registered 2005

Trademark Classifications

PierPass LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

36
Insurance & Financial (3 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does PierPass LLC have?

PierPass LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does PierPass LLC file in?

PierPass LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.

What are PierPass LLC's most well-known trademarks?

PierPass LLC's registered trademark portfolio includes well-known marks such as OFFPEAK and PIERPASS. These are among 3 currently registered trademarks in the portfolio.

What is PierPass LLC's trademark registration success rate?

PierPass LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.